Subscribe

InterCare DX, Inc. (ICCO)

USD0.00 +0.00 (+0.00%)
US OTC Technology Software - Application
Address 4477 West 118th Street 90250
Torrance, CA, US
CEO Anthony C. Dike
IPO 2009-07-24
CIK 1103310 ISIN US45845C1071

Explore sections of this company profile

Description

InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets. Its products comprise e-Learning Integrated Technology Enterprise Systems for integrated tuition, boarding and lodging management, enterprise vendor portal, customer relationship management, enterprise budgeting, and financial management, as well as other tools used in administering education at all levels; InterCare Clinical Explorer, a software application designed to integrate virtually all aspects of the healthcare enterprise; and InterCare Vascular Diagnostic Center to measure vascular health in patients before exhibiting symptoms. The company was formerly known as InterCare Diagnostics. InterCare DX, Inc. was founded in 1991 and is based in Hawthorne, California. InterCare DX, Inc.is a subsidiary of Meridian Holdings, Inc.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2.2K
Beta
-2.49
Float Shares
9.30M
Free Float %
46.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +0.00% +0.00% -97.22% -99.64% -99.42% -96.67% -90.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-83,304.38
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Software - Application: +13.0%
  • EPS growth Software - Application: +28.6%
    -22.4% Q2'23: -8.7% (vs Q2'22)
  • FCF margin FCF growth · Software - Application: +45.3%
  • EBIT margin Software - Application: +9.4%
  • ROIC Software - Application: +7.5%
    Q2'23: +0.0% (vs Q2'22)
  • Share dilution Software - Application: +0.0%
    +0.0% Q2'23: +0.0% (vs Q2'22)
  • Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-1.66) × ERP
WACC = 0% × Ke + 100% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Ownership data is not available for this company yet.

Executive team

Top executives
Shares Outstanding
19.90M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2006-01-23 DEF 14A
2005-12-28 PRE 14A
2005-01-18 DEF 14A
2005-01-03 PRE 14A
2004-01-15 DEF 14A
2003-12-31 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2023-09-08 1-SA
2023-06-13 253G1
2023-06-12 QUALIF
2023-06-01 1-A POS
2023-04-18 1-K
2022-08-15 1-SA
2022-05-31 1-K
2021-09-22 1-SA
2021-07-09 QUALIF
2021-07-07 CORRESP

Executive team

NameTitleCompensationGender
Russ A. Lyon Chief Technology Officer 200.0K male
Anthony C. Dike Founder, Chairman, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Member of the Clinical Advisory Board
Donald L. Stanford Chief Technical Strategist and Director male
Jerry Miller Interim President and Interim Chief Operations Officer male
Kenneth Johnson Vice President of Business Development and Vice President of Finance male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits